Blueprint Medicines Statistics
Total Valuation
BPMC has a market cap or net worth of $5.90 billion. The enterprise value is $5.76 billion.
Important Dates
The last earnings date was Thursday, February 13, 2025, before market open.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BPMC has 63.91 million shares outstanding. The number of shares has increased by 3.80% in one year.
| Current Share Class | 63.91M |
| Shares Outstanding | 63.91M |
| Shares Change (YoY) | +3.80% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 105.31% |
| Float | 63.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.40 |
| Forward PS | 7.89 |
| PB Ratio | 19.68 |
| P/TBV Ratio | 19.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.85, with a Debt / Equity ratio of 2.43.
| Current Ratio | 2.85 |
| Quick Ratio | 2.66 |
| Debt / Equity | 2.43 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.08 |
Financial Efficiency
Return on equity (ROE) is -31.26% and return on invested capital (ROIC) is -13.75%.
| Return on Equity (ROE) | -31.26% |
| Return on Assets (ROA) | -11.89% |
| Return on Invested Capital (ROIC) | -13.75% |
| Return on Capital Employed (ROCE) | -23.07% |
| Revenue Per Employee | $784,012 |
| Profits Per Employee | -$103,373 |
| Employee Count | 649 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 1.16 |
Taxes
In the past 12 months, BPMC has paid $1.23 million in taxes.
| Income Tax | 1.23M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.10% in the last 52 weeks. The beta is 0.62, so BPMC's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +1.10% |
| 50-Day Moving Average | 99.50 |
| 200-Day Moving Average | 98.64 |
| Relative Strength Index (RSI) | 34.05 |
| Average Volume (20 Days) | 1,059,506 |
Short Selling Information
The latest short interest is 4.21 million, so 6.59% of the outstanding shares have been sold short.
| Short Interest | 4.21M |
| Short Previous Month | 5.14M |
| Short % of Shares Out | 6.59% |
| Short % of Float | 6.66% |
| Short Ratio (days to cover) | 4.73 |
Income Statement
In the last 12 months, BPMC had revenue of $508.82 million and -$67.09 million in losses. Loss per share was -$1.07.
| Revenue | 508.82M |
| Gross Profit | 488.66M |
| Operating Income | -212.04M |
| Pretax Income | -204.95M |
| Net Income | -67.09M |
| EBITDA | -195.75M |
| EBIT | -212.04M |
| Loss Per Share | -$1.07 |
Full Income StatementBalance Sheet
The company has $615.49 million in cash and $724.28 million in debt, giving a net cash position of $139.66 million or $2.19 per share.
| Cash & Cash Equivalents | 615.49M |
| Total Debt | 724.28M |
| Net Cash | 139.66M |
| Net Cash Per Share | $2.19 |
| Equity (Book Value) | 298.67M |
| Book Value Per Share | 4.69 |
| Working Capital | 481.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$192.59 million and capital expenditures -$4.63 million, giving a free cash flow of -$197.22 million.
| Operating Cash Flow | -192.59M |
| Capital Expenditures | -4.63M |
| Free Cash Flow | -197.22M |
| FCF Per Share | -$3.09 |
Full Cash Flow StatementMargins
Gross margin is 96.04%, with operating and profit margins of -41.67% and -13.19%.
| Gross Margin | 96.04% |
| Operating Margin | -41.67% |
| Pretax Margin | -12.94% |
| Profit Margin | -13.19% |
| EBITDA Margin | -38.47% |
| EBIT Margin | -41.67% |
| FCF Margin | n/a |
Dividends & Yields
BPMC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.80% |
| Shareholder Yield | -3.80% |
| Earnings Yield | -1.14% |
| FCF Yield | -3.35% |
Dividend DetailsAnalyst Forecast
The average price target for BPMC is $123.61, which is 34.00% higher than the current price. The consensus rating is "Buy".
| Price Target | $123.61 |
| Price Target Difference | 34.00% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 27.04% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BPMC has an Altman Z-Score of 1.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.48 |
| Piotroski F-Score | 3 |